Peter Zimetbaum
Beth Israel Deaconess Medical Center
Internal medicineSurgeryCardiologyIntensive care medicineProspective cohort studySinus rhythmCatheter ablationVentricular tachycardiaAmiodaroneHeart failureAtrial flutterAtrial fibrillationElectrocardiographyHeart diseaseTachycardiaPopulationAnesthesiaMyocardial infarctionStrokeMedical emergencyMedicine
224Publications
59H-index
7,891Citations
Publications 222
Newest
#1David Shim (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 8
#2Timothy Richard Maher (BIDMC: Beth Israel Deaconess Medical Center)
Last. André D'Avila (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 3
view all 6 authors...
Source
#1Jason Matos (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 6
#2Susan McIlvaine (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 1
Last. Peter Zimetbaum (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 59
view all 9 authors...
Abstract Objective We sought to elucidate national practice patterns regarding anticoagulation and antiarrhythmic medication use at discharge and examine short-term patient outcomes. Methods In this retrospective cohort study, we analyzed patient data from the Society of Thoracic Surgery (STS) Adult Cardiac Surgery Database from July 2011-June 2018 who underwent first-time isolated coronary artery bypass graft surgery (CABG) and developed new post-CABG atrial fibrillation (AF) without significan...
9 CitationsSource
#2Rahul KhannaH-Index: 6
Last. Peter ZimetbaumH-Index: 59
view all 8 authors...
Source
#1Mark K. Tuttle (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 4
#2Nicholas Spetko (BIDMC: Beth Israel Deaconess Medical Center)
Last. Peter Zimetbaum (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 59
view all 7 authors...
Perfect adherence to anticoagulant medications is an important aspect of care for patients with atrial fibrillation undergoing cardiac electrophysiology procedures to minimize the risk of stroke. Despite this, adherence remains imperfect as is associated with added cost of additional procedures (e.g., transesophageal echocardiography) and administrative burden. We sought to identify characteristics of such patients and predictors of medication errors at Beth Israel Deaconess Medical Center. null...
Source
#1Demosthenes G Katritsis (Johns Hopkins University)
#2Joseph E. Marine (Johns Hopkins University)H-Index: 51
Last. Damián Sánchez-Quintana (University of Extremadura)H-Index: 41
view all 11 authors...
AIMS The exact circuit of atrioventricular nodal re-entrant tachycardia (AVNRT) remains elusive. To assess the location and dimensions of the AVNRT circuit. METHODS AND RESULTS Both typical and atypical AVNRT were induced at electrophysiology study of 14 patients. We calculated the activation time of the fast and slow pathways, and consequently, the length of the slow pathway, by assuming an average conduction velocity of 0.04 mm/ms in the nodal area. The distance between the compact atrioventri...
Source
#1Melissa Tsoi (BIDMC: Beth Israel Deaconess Medical Center)
Last. William H. FrishmanH-Index: 62
view all 4 authors...
Conduction disturbances and permanent pacemaker implantation (PPMI) remain a frequent and important consequence of transcatheter aortic valve replacement (TAVR). Understanding risk factors for TAVR-related conduction disturbances could improve patient selection, procedural techniques, and peri-procedural efforts for monitoring and treatment of heart block. Several studies have identified patient-related and procedural factors associated with new-onset left bundle branch block, high-degree atriov...
Source
#1Nicholas O. Palmeri (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 5
#2Daniel B. Kramer (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 43
Last. Peter Zimetbaum (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 59
view all 4 authors...
Cardiovascular implantable electronic device (CIED) infections are morbid, costly, and difficult to manage. This review explores the pathophysiology, diagnosis, and management of CIED infections. Diagnostic accuracy has been improved through increased awareness and improved imaging strategies. Pocket or bloodstream infection with virulent organisms often requires complete system extraction. Emerging prophylactic interventions and novel devices have expanded preventative strategies and options fo...
Source
#1Andrew LockeH-Index: 6
#2Michael I Gurin (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 1
Last. Peter ZimetbaumH-Index: 59
view all 5 authors...
Cardiac sarcoidosis (CS) is a complex disease that can manifest as a diverse array of arrhythmias. CS patients may be at higher risk for sudden cardiac death (SCD), and in some cases, SCD may be the first presenting symptom of the underlying disease. As such, identification, risk stratification, and management of CS-related arrhythmia are crucial in the care of these patients. Left untreated, CS carries significant arrhythmogenic morbidity and mortality. Cardiac manifestations of CS are a conseq...
1 CitationsSource
#1Andrew Locke (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 6
#2David Shim (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 8
Last. Peter Zimetbaum (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 59
view all 8 authors...
Superior vena cava (SVC) syndrome is a rare complication associated with transvenous cardiac implantable electronic devices that may present with a variety of manifestations. Various strategies such as transvenous lead extraction, anticoagulation, venoplasty, and stenting have been used to treat this condition, but the optimal management protocols have yet to be defined. Subcutaneous implantable cardioverter-defibrillator (ICD) (S-ICD) therapy can be an alternative option to a transvenous system...
Source
#1Robert N. D’ Angelo (BIDMC: Beth Israel Deaconess Medical Center)
#1Robert N. D'Angelo (BIDMC: Beth Israel Deaconess Medical Center)
Last. Peter Zimetbaum (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 59
view all 9 authors...
INTRODUCTION Antiarrhythmic drugs (AADs) are commonly used for the treatment of newly-diagnosed symptomatic atrial fibrillation (AF), however initial AAD choice, duration of therapy, rates of discontinuation and factors associated with a durable response to therapy are poorly understood. This study assesses initial choice and duration of antiarrhythmic drug therapy in the first two years after diagnosis of atrial fibrillation in a younger, commercially-insured population. METHODS A large nationa...
Source